A retrospective study of elevated post-operative parathormone in primary hyperparathyroid patients

Shaobo Cao, Ya Hu, Yiming Zhao, Zhe Su, Zhiyan Xu, Xiang Gao, Quan Liao, Yupei Zhao

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We retrospectively analyzed the relationship between normocalcemic parathormone elevation (NPE) and recurrence of primary hyperparathyroidism (pHPT) after surgery, as well as the risk factors of NPE. Out of 309 patients with pHPT that underwent parathyroidectomy. Six months after surgery, 75 patients exhibited NPE with high preoperative serum levels of alkaline phosphatase, calcium and intact parathyroid hormone (iPTH), postoperative day 1 iPTH, and large parathyroid volume. 15 exhibited NPE at 2 years after surgery with low serum vitamin D levels. Postoperative serum iPTH levels gradually normalized in most patients. Multivariate analysis showed that male patients were at greater risk for postoperative NPE (p < 0.05). Only 3 of 309 patients showed recurrence during the follow-up period. NPE may not predict recurrent hyperparathyroidism or incomplete parathyroidectomy for benign parathyroid lesions. Postoperative NPE thus appears to be a response to severe hyperparathyroidism and vitamin D deficiency.

Original languageEnglish (US)
Pages (from-to)101158-101164
Number of pages7
JournalOncotarget
Volume8
Issue number60
DOIs
StatePublished - Jan 1 2017

Fingerprint

Parathyroid Hormone
Retrospective Studies
Parathyroidectomy
Primary Hyperparathyroidism
Hyperparathyroidism
Serum
Recurrence
Vitamin D Deficiency
Vitamin D
Alkaline Phosphatase
Multivariate Analysis
Calcium

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Cao, Shaobo ; Hu, Ya ; Zhao, Yiming ; Su, Zhe ; Xu, Zhiyan ; Gao, Xiang ; Liao, Quan ; Zhao, Yupei. / A retrospective study of elevated post-operative parathormone in primary hyperparathyroid patients. In: Oncotarget. 2017 ; Vol. 8, No. 60. pp. 101158-101164.
@article{a8cd5bd23bff455eba04d1648467e8ad,
title = "A retrospective study of elevated post-operative parathormone in primary hyperparathyroid patients",
abstract = "We retrospectively analyzed the relationship between normocalcemic parathormone elevation (NPE) and recurrence of primary hyperparathyroidism (pHPT) after surgery, as well as the risk factors of NPE. Out of 309 patients with pHPT that underwent parathyroidectomy. Six months after surgery, 75 patients exhibited NPE with high preoperative serum levels of alkaline phosphatase, calcium and intact parathyroid hormone (iPTH), postoperative day 1 iPTH, and large parathyroid volume. 15 exhibited NPE at 2 years after surgery with low serum vitamin D levels. Postoperative serum iPTH levels gradually normalized in most patients. Multivariate analysis showed that male patients were at greater risk for postoperative NPE (p < 0.05). Only 3 of 309 patients showed recurrence during the follow-up period. NPE may not predict recurrent hyperparathyroidism or incomplete parathyroidectomy for benign parathyroid lesions. Postoperative NPE thus appears to be a response to severe hyperparathyroidism and vitamin D deficiency.",
author = "Shaobo Cao and Ya Hu and Yiming Zhao and Zhe Su and Zhiyan Xu and Xiang Gao and Quan Liao and Yupei Zhao",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.20416",
language = "English (US)",
volume = "8",
pages = "101158--101164",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "60",

}

A retrospective study of elevated post-operative parathormone in primary hyperparathyroid patients. / Cao, Shaobo; Hu, Ya; Zhao, Yiming; Su, Zhe; Xu, Zhiyan; Gao, Xiang; Liao, Quan; Zhao, Yupei.

In: Oncotarget, Vol. 8, No. 60, 01.01.2017, p. 101158-101164.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A retrospective study of elevated post-operative parathormone in primary hyperparathyroid patients

AU - Cao, Shaobo

AU - Hu, Ya

AU - Zhao, Yiming

AU - Su, Zhe

AU - Xu, Zhiyan

AU - Gao, Xiang

AU - Liao, Quan

AU - Zhao, Yupei

PY - 2017/1/1

Y1 - 2017/1/1

N2 - We retrospectively analyzed the relationship between normocalcemic parathormone elevation (NPE) and recurrence of primary hyperparathyroidism (pHPT) after surgery, as well as the risk factors of NPE. Out of 309 patients with pHPT that underwent parathyroidectomy. Six months after surgery, 75 patients exhibited NPE with high preoperative serum levels of alkaline phosphatase, calcium and intact parathyroid hormone (iPTH), postoperative day 1 iPTH, and large parathyroid volume. 15 exhibited NPE at 2 years after surgery with low serum vitamin D levels. Postoperative serum iPTH levels gradually normalized in most patients. Multivariate analysis showed that male patients were at greater risk for postoperative NPE (p < 0.05). Only 3 of 309 patients showed recurrence during the follow-up period. NPE may not predict recurrent hyperparathyroidism or incomplete parathyroidectomy for benign parathyroid lesions. Postoperative NPE thus appears to be a response to severe hyperparathyroidism and vitamin D deficiency.

AB - We retrospectively analyzed the relationship between normocalcemic parathormone elevation (NPE) and recurrence of primary hyperparathyroidism (pHPT) after surgery, as well as the risk factors of NPE. Out of 309 patients with pHPT that underwent parathyroidectomy. Six months after surgery, 75 patients exhibited NPE with high preoperative serum levels of alkaline phosphatase, calcium and intact parathyroid hormone (iPTH), postoperative day 1 iPTH, and large parathyroid volume. 15 exhibited NPE at 2 years after surgery with low serum vitamin D levels. Postoperative serum iPTH levels gradually normalized in most patients. Multivariate analysis showed that male patients were at greater risk for postoperative NPE (p < 0.05). Only 3 of 309 patients showed recurrence during the follow-up period. NPE may not predict recurrent hyperparathyroidism or incomplete parathyroidectomy for benign parathyroid lesions. Postoperative NPE thus appears to be a response to severe hyperparathyroidism and vitamin D deficiency.

UR - http://www.scopus.com/inward/record.url?scp=85034810602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034810602&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.20416

DO - 10.18632/oncotarget.20416

M3 - Article

C2 - 29254153

AN - SCOPUS:85034810602

VL - 8

SP - 101158

EP - 101164

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 60

ER -